Edition:
India

People: Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

2.02USD
21 Feb 2020
Change (% chg)

$-0.08 (-3.81%)
Prev Close
$2.10
Open
$2.08
Day's High
$2.12
Day's Low
$2.02
Volume
37,006
Avg. Vol
285,122
52-wk High
$8.18
52-wk Low
$0.35

McHale, Mark 

Mr. Mark McHale has been serving as Chief Operating Officer in ASLAN PHARMACEUTICALS LIMITED since February 7, 2011. He holds a Bachelor's degree in Biology from University of London, the United Kingdom, and a Ph.D. in Molecular Biology from University of East Anglia, the United Kingdom. He is also Director in Match Point Developments Limited and a Shanghai-based company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --